Log In
Print
BCIQ
Print
Print this Print this
 

QBECO

  Manage Alerts
Collapse Summary General Information
Company Qu Biologics Inc.
DescriptionSite-specific immunomodulator containing single species of killed bacteria to stimulate the innate immune system
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I/II
Standard IndicationCrohn's disease
Indication DetailsTreat moderate to severe Crohn's disease
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today